Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images

Nanchong Central Hospital

Status: Completed

Conditions: Lymph Node Metastasis; Papillary Thyroid Carcinoma

Treatments: Procedure: Thyroidectomy and lymph node dissection

Study type: Observational

Funder types: Other

Identifiers

NCT06399159

Review-2023-109

Details and patient eligibility

About

Rising thyroid carcinoma rates, with papillary thyroid carcinoma (PTC) as the main type (85-90% of cases), often show early cervical lymph node spread. This increases the risk of PTC patients for recurrence and death. A new study's multimodal model fuses preoperative US and cytology images to better predict lymph node metastasis, aiming to improve treatment plans, reduce unnecessary surgeries, and enhance patient outcomes.

Full description

Thyroid carcinoma incidence has been on the rise in recent years. Papillary thyroid carcinoma is the most prevalent type of differentiated thyroid carcinoma, accounting for 85% to 90% of malignant thyroid tumors. Despite its indolent nature, cervical lymph node metastasis is frequently observed at an early stage. Papillary thyroid carcinoma patients with cervical lymph node metastasis face an elevated risk of recurrence, distant metastasis, and mortality. Thus, non-invasive preoperative prediction of cervical lymph node metastasis is particularly vital for guiding treatment plans and prognostic. this study has developed a multimodal model integrating preoperative US images with cytological images of papillary thyroid carcinoma patients. The aim is to enhance the predictive accuracy for cervical lymph node metastasis, reduce unnecessary lymph node dissections, and provide real-time, precise guidance for determining the extent of surgical resection and prognostic assessment. This approach aims to optimize patient treatment strategies and enhance therapeutic outcomes.

Enrollment: 1,500 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Underwent thyroidectomy and bilateral lymph node dissection with pathological confirmation of PTC
• Completed US examination within one week before surgery
• Underwent preoperative us-guided FNAC
• Completed cytological images at 400× magnification under a microscope

Exclusion criteria

• Patients who underwent only unilateral thyroidectomy
• Patients with cervical lymph nodes shown on preoperative ultrasound

Trial design

1,500 participants in 2 patient groups

Cohort with Lymph Node Metastasis

Description:

Depending on the pathological findings, it is classified as the presence of lymph node metastases.

Treatment:

Procedure: Thyroidectomy and lymph node dissection

Cohort without Lymph Node Metastasis

Description:

Depending on the pathological findings, it is classified as the absence of lymph node metastases.

Treatment:

Procedure: Thyroidectomy and lymph node dissection